Home > Analytics > MOREPEN LABORATORIES

MOREPEN LABORATORIES
Intrinsic Value | Fundamental Analysis

BOM : 500288     NSE : MOREPENLAB    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
May 18,2024
Price(EOD): ₹ 47.87
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 2,447.11 Cr
Value of ₹ 1 Lac invested in MOREPEN LABORATORIES
on May 20,2019 (price: ₹ 19.85)

₹ 1 L

₹ 2.41 L

1W : 3.2% 1M : 2.8% 1Y : 73.2%
COMMUNITY POLL
for MOREPEN LABORATORIES
Please provide your vote to see the results
MOREPEN LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
MOREPEN LABORATORIES 3.2% 2.8% 73.2%
SUN PHARMACEUTICAL INDUSTRIES -0.9% 0.9% 62.6%
CIPLA 3.5% 4.2% 51.8%
DR REDDYS LABORATORIES -1% -2.4% 28.4%
ZYDUS LIFESCIENCES 12.2% 18% 103.8%
DIVIS LABORATORIES 0.8% 5.6% 19.3%
MANKIND PHARMA -6.1% -11.9% 54.1%
TORRENT PHARMACEUTICALS 2.9% 6.2% 66.2%
LUPIN 1.5% 4.2% 109.2%

FUNDAMENTAL ANALYSIS OF MOREPEN LABORATORIES

 
Fundamentals Score
[ Q(TTM): Dec2023, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF MOREPEN LABORATORIES

 
Valuation Score
[As on : May 18,2024 ]

Ratio Consolidated
P/E
P/B
P/S
32.15
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 76.12 Cr
[Latest Qtr - Dec2023 - Consolidated Results ]

3.25
P/B Calculated based on Book Value of Rs 752.91 Cr
[Latest Year - Mar2023 - Consolidated Results ]

1.5
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,631.04 Cr
[Latest Qtr - Dec2023 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 12% undervalued companies ! Discover More →

FAIR VALUE OF MOREPEN LABORATORIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
94%
13%
16%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF MOREPEN LABORATORIES



MOREPEN LABORATORIES vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF MOREPEN LABORATORIES

Year Debt/Equity ratio
Standalone Consolidated
2023
2022
2021
Avg_3yrs
0.03
0.03
0.04
0.03
0.03
0.03
0.04
0.03
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF MOREPEN LABORATORIES

Pledged Promoter Shares
0 %
As on : Dec2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF MOREPEN LABORATORIES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
5.4%
50.54%
53.48%
50.5%
27.57%
146.43%
214.41%
255.69%
QtrlyTrend
8
Latest Qtr: Dec2023
Quarterly Result Analysis →


MOREPEN LABORATORIES related INDICES

BSE Indices1W1M1Y
S&P BSE SMALL CAP 5.9% 5.6% 61.1%
S&P BSE MIDSMALLCAP 5.2% 6.2% 62.2%
S&P BSE ALLCAP 3.2% 3.6% 36.9%
S&P BSE HEALTHCARE 1.6% 1.9% 53.4%
No NSE index found

You may also like the below Video Courses


FAQ about MOREPEN LABORATORIES


Is MOREPEN LABORATORIES good for long term investment?

As on May 18,2024, the Fundamentals of MOREPEN LABORATORIES look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of MOREPEN LABORATORIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is MOREPEN LABORATORIES UnderValued or OverValued?

As on May 18,2024, MOREPEN LABORATORIES is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of MOREPEN LABORATORIES ?

As on May 18,2024, the Intrinsic Value of MOREPEN LABORATORIES is Rs. 41.35 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 24.65
Fair Value [Median EV / Sales Model] : Rs. 42.41
Fair Value [Median Price / Sales Model] : Rs. 41.35
Estimated Median Fair Value of MOREPEN LABORATORIES : Rs. 41.35

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is MOREPEN LABORATORIES trading at a Premium or Discount?

As on May 18,2024, MOREPEN LABORATORIES is trading at a Premium of 16% based on the estimates of Median Intrinsic Value!